<DOC>
	<DOCNO>NCT01588119</DOCNO>
	<brief_summary>Patients , adjust new oral anticoagulant ( Dabigatran , Rivaroxaban , Apixaban , Edoxaban ) routine treatment record register . Within register characterization patient ( regard demography indication ) therapy ( regard medication , dose duration ) do . On basis define clinical relevant end point long-term efficacy safety evaluate .</brief_summary>
	<brief_title>Register New Oral Anticoagulants</brief_title>
	<detailed_description />
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>indication treatment long term anticoagulation initial adjustment change nex oral anticoagulant within routine treatment indication treatment long term anticoagulation within register : permanent anticoagulation arterial fibrillation intend anticoagulation acute venous thromboembolism min . 3 month anticoagulation min . 3 month within approve indication miss Informed Consent Form miss phone number telephone follow contraindication therapy new oral anticoagulant ( Dabigatran , Rivaroxaban , Apixaban , Edoxaban ) accord Summary Product Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>